DK0601053T3 - Præparater og fremgangsmåder til den sublinguale eller bukkale indgivelse af terapeutiske midler - Google Patents
Præparater og fremgangsmåder til den sublinguale eller bukkale indgivelse af terapeutiske midlerInfo
- Publication number
- DK0601053T3 DK0601053T3 DK92918805T DK92918805T DK0601053T3 DK 0601053 T3 DK0601053 T3 DK 0601053T3 DK 92918805 T DK92918805 T DK 92918805T DK 92918805 T DK92918805 T DK 92918805T DK 0601053 T3 DK0601053 T3 DK 0601053T3
- Authority
- DK
- Denmark
- Prior art keywords
- sublingual
- therapeutic agents
- buccal administration
- compositions
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Physiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75084391A | 1991-08-26 | 1991-08-26 | |
PCT/US1992/006944 WO1993003751A1 (en) | 1991-08-26 | 1992-08-18 | Compositions and methods for the sublingual or buccal administration of therapeutic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0601053T3 true DK0601053T3 (da) | 2001-01-08 |
Family
ID=25019382
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK92918805T DK0601053T3 (da) | 1991-08-26 | 1992-08-18 | Præparater og fremgangsmåder til den sublinguale eller bukkale indgivelse af terapeutiske midler |
Country Status (14)
Country | Link |
---|---|
US (1) | US5284657A (xx) |
EP (1) | EP0601053B1 (xx) |
JP (1) | JPH06510046A (xx) |
KR (1) | KR100256715B1 (xx) |
AT (1) | ATE197126T1 (xx) |
AU (1) | AU669856B2 (xx) |
CA (1) | CA2103163C (xx) |
DE (1) | DE69231536T2 (xx) |
DK (1) | DK0601053T3 (xx) |
ES (1) | ES2153362T3 (xx) |
GR (1) | GR3035116T3 (xx) |
IL (1) | IL102857A (xx) |
PT (1) | PT100812B (xx) |
WO (1) | WO1993003751A1 (xx) |
Families Citing this family (72)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5487898A (en) * | 1991-08-26 | 1996-01-30 | Abbott Laboratories | Compositions and method for the sublingual or buccal administration therapeutic agents |
US5567592A (en) * | 1994-02-02 | 1996-10-22 | Regents Of The University Of California | Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal |
US5716928A (en) * | 1995-06-07 | 1998-02-10 | Avmax, Inc. | Use of essential oils to increase bioavailability of oral pharmaceutical compounds |
US7833543B2 (en) | 1995-06-07 | 2010-11-16 | Durect Corporation | High viscosity liquid controlled delivery system and medical or surgical device |
ATE287673T1 (de) * | 1995-06-07 | 2005-02-15 | Southern Biosystems Inc | Kontrolliertes zuführsystem mit einer flüssigkeit von hoher viskosität |
US5665386A (en) * | 1995-06-07 | 1997-09-09 | Avmax, Inc. | Use of essential oils to increase bioavailability of oral pharmaceutical compounds |
US5916566A (en) * | 1995-06-07 | 1999-06-29 | Avmax, Inc. | Use of benzoin gum to inhibit P-glycoprotein-mediated resistance of pharmaceutical compounds |
WO1997011709A1 (en) * | 1995-09-25 | 1997-04-03 | Ashmont Holdings Limited | Anthelmintic macrocyclic lactone compositions |
US6949264B1 (en) | 1996-11-27 | 2005-09-27 | Wm. Wrigley Jr. Company | Nutraceuticals or nutritional supplements and method of making |
EP0880969A1 (en) * | 1997-05-28 | 1998-12-02 | Applied Research Systems ARS Holdings N.V. | Pharmaceutical compositions of peptides having low solubility in physiological medium |
US20030095925A1 (en) * | 1997-10-01 | 2003-05-22 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders |
US20040136914A1 (en) * | 1997-10-01 | 2004-07-15 | Dugger Harry A. | Buccal, polar and non-polar spray containing ondansetron |
EP1029536B1 (en) | 1997-10-01 | 2007-11-28 | Novadel Pharma Inc. | Buccal non-polar spray |
US7632517B2 (en) | 1997-10-01 | 2009-12-15 | Novadel Pharma Inc. | Buccal, polar and non-polar spray containing zolpidem |
PT1510213E (pt) | 1997-11-10 | 2009-02-12 | Strakan Internat Ltd Uma Socie | Sistemas de melhoramento de penetração e reduzida irritação incluíndo testosterona |
WO1999043299A2 (en) * | 1998-02-26 | 1999-09-02 | Abbott Laboratories | Oral formulation for hydrophilic drugs |
EP1137431A1 (en) * | 1998-12-04 | 2001-10-04 | Provalis UK Limited | Pharmaceutical compositions containing insulin |
US6586023B1 (en) | 1998-12-15 | 2003-07-01 | Wm. Wrigley Jr. Company | Process for controlling release of active agents from a chewing gum coating and product thereof |
US6627234B1 (en) | 1998-12-15 | 2003-09-30 | Wm. Wrigley Jr. Company | Method of producing active agent coated chewing gum products |
US7163705B2 (en) * | 1998-12-15 | 2007-01-16 | Wm. Wrigley Jr. Company | Coated chewing gum product and method of making |
US6531114B1 (en) | 1999-04-06 | 2003-03-11 | Wm. Wrigley Jr. Company | Sildenafil citrate chewing gum formulations and methods of using the same |
US6242473B1 (en) | 1999-01-08 | 2001-06-05 | Maxim Pharmaceuticals, Inc. | Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
US6773716B2 (en) | 1999-04-06 | 2004-08-10 | Wm. Wrigley Jr. Company | Over-coated chewing gum formulations |
US6426090B1 (en) * | 1999-04-06 | 2002-07-30 | Wm. Wrigley Jr. Company | Over-coated product including tableted center and medicament |
US7935362B2 (en) * | 1999-04-06 | 2011-05-03 | Wm. Wrigley Jr. Company | Over-coated product including consumable center and medicament |
US20020159956A1 (en) * | 1999-04-06 | 2002-10-31 | Ream Ronald L. | Over-coated chewing gum formulations |
US6355265B1 (en) | 1999-04-06 | 2002-03-12 | Wm. Wrigley Jr. Company | Over-coated chewing gum formulations |
US6322806B1 (en) | 1999-04-06 | 2001-11-27 | Wm. Wrigley Jr. Company | Over-coated chewing gum formulations including tableted center |
EP1187639A1 (en) | 1999-06-04 | 2002-03-20 | Delrx Pharmaceutical Corporation | Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same |
US6569472B1 (en) | 2000-09-01 | 2003-05-27 | Wm. Wrigley Jr. Company | Coated chewing gum products containing antacid and method of making |
US6541048B2 (en) | 1999-09-02 | 2003-04-01 | Wm. Wrigley Jr. Company | Coated chewing gum products containing an acid blocker and process of preparing |
US6663849B1 (en) | 2000-09-01 | 2003-12-16 | Wm. Wrigley Jr. Company | Antacid chewing gum products coated with high viscosity materials |
US6645535B2 (en) | 1999-09-02 | 2003-11-11 | Wm. Wrigley Jr. Company | Method of making coated chewing gum products containing various antacids |
WO2001021147A1 (en) * | 1999-09-20 | 2001-03-29 | Mastercare | Diet and weight control gum and sucker |
US9253991B2 (en) | 1999-09-20 | 2016-02-09 | Jack Barreca | Chewing gum with B vitamins |
US9387168B2 (en) | 1999-09-20 | 2016-07-12 | Jack Barreca | Chewing gum with tomatidine |
US7115288B2 (en) * | 2000-06-09 | 2006-10-03 | Wm. Wrigley Jr. Company | Method for making coated chewing gum products with a coating including an aldehyde flavor and a dipeptide sweetener |
US6572900B1 (en) | 2000-06-09 | 2003-06-03 | Wm. Wrigley, Jr. Company | Method for making coated chewing gum products including a high-intensity sweetener |
US6444241B1 (en) | 2000-08-30 | 2002-09-03 | Wm. Wrigley Jr. Company | Caffeine coated chewing gum product and process of making |
US6579545B2 (en) | 2000-12-22 | 2003-06-17 | Wm. Wrigley Jr. Company | Coated chewing gum products containing an antigas agent |
JP2005510501A (ja) * | 2001-10-19 | 2005-04-21 | マキシム ファーマシューティカルス,インコーポレイテッド | 肝臓疾患治療へのヒスタミンの使用 |
WO2003055494A1 (en) * | 2001-12-21 | 2003-07-10 | Avmax, Inc. | Use of ugt inhibitors to increase bioavailability |
US20040001889A1 (en) | 2002-06-25 | 2004-01-01 | Guohua Chen | Short duration depot formulations |
EP1534302A4 (en) * | 2002-08-22 | 2009-01-07 | Nutrition 21 Inc | ARGININILICATE / INOSITOL COMPLEX AND ITS USE |
CN101797221B (zh) | 2002-12-13 | 2013-06-12 | 杜雷科特公司 | 包含高粘度液体载体材料的口服递药系统 |
CN1738632A (zh) * | 2003-01-30 | 2006-02-22 | 科学与工业研究委员会 | 葛缕子提取物及其部分的生物利用度增强活性 |
CA2521221A1 (en) * | 2003-04-02 | 2004-10-14 | Genix Therapeutics, Inc. | Method for the treatment of prostate cancer |
CA2819769C (en) * | 2003-07-18 | 2016-06-28 | Oakwood Laboratories, L.L.C. | Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions |
JP4388322B2 (ja) * | 2003-07-31 | 2009-12-24 | 花王株式会社 | アポリポプロテインd分解抑制剤 |
US20050171192A1 (en) * | 2003-12-11 | 2005-08-04 | Gehlsen Kurt R. | Use of histamine to treat bone disease |
EP1761784B1 (en) | 2004-05-24 | 2016-10-26 | Universität Zu Köln | Identification of ergothioneine transporter and therapeutic uses thereof |
WO2006009975A2 (en) * | 2004-06-22 | 2006-01-26 | Maxim Pharmaceuticals, Inc. | Histamine to treat disorders affecting muscle function |
SI2767292T1 (sl) | 2004-09-17 | 2017-01-31 | Durect Corporation | Pripravek, ki vsebuje lokalni anestetik SAIB, s podaljšanim sproščanjem |
WO2007005995A2 (en) * | 2005-07-05 | 2007-01-11 | Emisphere Technologies, Inc. | Compositions for buccal delivery of human growth hormone |
US8975227B2 (en) | 2005-07-15 | 2015-03-10 | Emisphere Technologies, Inc. | Intraoral dosage forms of glucagon |
US20070027105A1 (en) | 2005-07-26 | 2007-02-01 | Alza Corporation | Peroxide removal from drug delivery vehicle |
US20090054333A1 (en) * | 2006-10-17 | 2009-02-26 | Antonio Giordano | Peptide inhibitors of cyclin-dependent kinase activity and uses thereof |
ES2388355T3 (es) | 2006-11-03 | 2012-10-11 | Durect Corporation | Sistemas de suministro transdémico que comprenden bupivacaína |
AU2008347158B8 (en) | 2007-12-06 | 2013-08-22 | Durect Corporation | Oral pharmaceutical dosage forms |
PT2296686E (pt) | 2008-05-21 | 2014-05-23 | Ferring Bv | Desmopressina orodispersível para aumentar o período inicial de sono não perturbado por noctúria |
US20100286045A1 (en) | 2008-05-21 | 2010-11-11 | Bjarke Mirner Klein | Methods comprising desmopressin |
US11963995B2 (en) | 2008-05-21 | 2024-04-23 | Ferring B.V. | Methods comprising desmopressin |
US20100260844A1 (en) | 2008-11-03 | 2010-10-14 | Scicinski Jan J | Oral pharmaceutical dosage forms |
CA2780274C (en) | 2009-11-09 | 2018-06-26 | Spotlight Technology Partners Llc | Fragmented hydrogels |
AU2010314992B2 (en) | 2009-11-09 | 2016-09-15 | Spotlight Technology Partners Llc | Polysaccharide based hydrogels |
WO2014144975A1 (en) | 2013-03-15 | 2014-09-18 | Durect Corporation | Compositions with a rheological modifier to reduce dissolution variability |
US11191735B2 (en) | 2015-03-13 | 2021-12-07 | Nutrition 21, Llc | Arginine silicate for periodontal disease |
US20170135969A1 (en) | 2015-11-12 | 2017-05-18 | Jds Therapeutics, Llc | Topical arginine-silicate-inositol for wound healing |
JP2019526638A (ja) | 2016-09-01 | 2019-09-19 | ジェイディーエス・セラピューティクス、エルエルシー | ビオチン酸マグネシウム組成物および使用方法 |
CN113329680A (zh) | 2018-11-02 | 2021-08-31 | 营养21有限责任公司 | 用于改善视频游戏者认知功能的含有肌醇稳定的精氨酸硅酸盐复合物和肌醇的组合物 |
EP4076413A1 (en) | 2019-12-16 | 2022-10-26 | Nutrition 21, LLC | Methods of production of arginine-silicate complexes |
CN115666621A (zh) | 2020-01-13 | 2023-01-31 | 度勒科特公司 | 具有减少的杂质的持续释放药物递送系统及相关方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4244946A (en) * | 1979-06-11 | 1981-01-13 | The Salk Institute For Biological Studies | Water-soluble peptides affecting gonadal function |
US4382922A (en) * | 1980-08-29 | 1983-05-10 | The Salk Institute For Biological Studies | Peptides affecting gonadal function |
US4632979A (en) * | 1984-06-18 | 1986-12-30 | Tulane Educational Fund | Therapeutic LHRH analogs |
US4801577A (en) * | 1987-02-05 | 1989-01-31 | Syntex (U.S.A.) Inc. | Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists |
WO1990008537A1 (en) * | 1989-02-06 | 1990-08-09 | Abbott Laboratories | Pharmaceutical compositions for oral administration |
-
1992
- 1992-08-18 DE DE69231536T patent/DE69231536T2/de not_active Expired - Fee Related
- 1992-08-18 ES ES92918805T patent/ES2153362T3/es not_active Expired - Lifetime
- 1992-08-18 WO PCT/US1992/006944 patent/WO1993003751A1/en active IP Right Grant
- 1992-08-18 KR KR1019930703608A patent/KR100256715B1/ko not_active IP Right Cessation
- 1992-08-18 AU AU25193/92A patent/AU669856B2/en not_active Ceased
- 1992-08-18 IL IL10285792A patent/IL102857A/xx not_active IP Right Cessation
- 1992-08-18 CA CA002103163A patent/CA2103163C/en not_active Expired - Fee Related
- 1992-08-18 EP EP92918805A patent/EP0601053B1/en not_active Expired - Lifetime
- 1992-08-18 DK DK92918805T patent/DK0601053T3/da active
- 1992-08-18 AT AT92918805T patent/ATE197126T1/de not_active IP Right Cessation
- 1992-08-18 JP JP5504536A patent/JPH06510046A/ja active Pending
- 1992-08-25 PT PT100812A patent/PT100812B/pt not_active IP Right Cessation
- 1992-11-30 US US07/983,111 patent/US5284657A/en not_active Expired - Fee Related
-
2000
- 2000-12-19 GR GR20000402804T patent/GR3035116T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0601053A4 (en) | 1996-07-17 |
ES2153362T3 (es) | 2001-03-01 |
PT100812A (pt) | 1993-09-30 |
IL102857A (en) | 1997-02-18 |
PT100812B (pt) | 1999-07-30 |
IL102857A0 (en) | 1993-01-31 |
US5284657A (en) | 1994-02-08 |
CA2103163C (en) | 1998-10-20 |
EP0601053B1 (en) | 2000-10-25 |
AU669856B2 (en) | 1996-06-27 |
AU2519392A (en) | 1993-03-16 |
ATE197126T1 (de) | 2000-11-15 |
CA2103163A1 (en) | 1993-03-04 |
JPH06510046A (ja) | 1994-11-10 |
KR100256715B1 (ko) | 2000-05-15 |
DE69231536T2 (de) | 2001-06-13 |
WO1993003751A1 (en) | 1993-03-04 |
GR3035116T3 (en) | 2001-03-30 |
DE69231536D1 (de) | 2000-11-30 |
EP0601053A1 (en) | 1994-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0601053T3 (da) | Præparater og fremgangsmåder til den sublinguale eller bukkale indgivelse af terapeutiske midler | |
DK0686151T3 (da) | Substituerede cycliske carbonylforbindelser og derivater deraf, der kan anvendes som retrovirale proteaseinhibitorer | |
GT199700095A (es) | Derivados 6,5-heterobiciclicos sustituidos. | |
NO981501L (no) | Dimer-selektive RXR modulatorer og fremgangsmÕte for anvendelse derav | |
DK0693285T3 (da) | Farmaceutiske præparater, der indeholder et bisphosphonat og et antiresorberende middel til inhibering af knogletab | |
FI940074A (fi) | Uudet valmisteet, jotka perustuvat taksaanien luokkaan kuuluviin johdannaisiin | |
DK0943328T3 (da) | Kombinationsterapi til profylakse og/eller behandling af godartet prostatahyperplasi | |
DK0389352T3 (da) | Hidtil ukendte 4-fluorbenzoederivater, fremgangsmåder til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
GT199700089A (es) | Derivados 6.6 o 6.7 -biciclicos sustituidos que contienen pirido o pirimido. | |
NO923142D0 (no) | Cykliske peptider og anvendelse derav | |
DK0530087T3 (da) | Hidtil ukendte naphthylethylurinstof- og naphthylethylthiourinstofforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
FI864559A0 (fi) | Nya insulinderivat och farmaceutiska preparat innehaollande dessa derivat. | |
ID18079A (id) | Komposisi farmasi yang mengandung bahan pemercepat osteogenesis | |
DE69330926D1 (de) | Isoxazolderivate zur Behandlung von Darmreizungssyndromen | |
DE69924846D1 (de) | Thyroidhormon-analoga und verfahren zu ihrer herstellung | |
HUP0200055A2 (hu) | 16-Hidroxi-ösztratriének és ezeket tartalmazó gyógyszerkészítmények | |
DK159590C (da) | Fremgangsmaade til forhindring af nedbrydning af thieno-pyridinderivater | |
DK0783521T3 (da) | Polypeptidforbindelser indeholdende D-2-alkyltryptophan, hvilke er i stand til at fremme frigivelsen af væksthormon | |
DK598288D0 (da) | Vaeskeformig farmaceutisk sammensaetning til behandling af hoste og oemhed i halsen | |
NO912271L (no) | Somatostatinpreparater, deres fremstilling og anvendelse. | |
NO963634D0 (no) | Antihostepreparat inneholdende et antihostemiddel og benzydamin | |
DE69227979D1 (de) | Modifizierte VIP-Derivate und sie enthaltende pharmazeutische Zusammensetzungen | |
DE59409140D1 (de) | Cyclosporin(e) enthaltende o/w Emulsion zur oralen Verabreichung | |
ATE145824T1 (de) | Aerosolformulierung enthaltend fusafungin | |
DE3778826D1 (de) | Bestaendige therapeutische zusammensetzungen, basierend auf hydrophobem pflanzlichem oel und verfahren zu ihrer herstellung. |